These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3252975)

  • 21. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
    Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
    J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
    Veeken HJ; Ebeling MC; Dolmans WM
    Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
    Rodgers J; Bradley B; Kennedy PG
    Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
    Haller L; Adams H; Merouze F; Dago A
    Am J Trop Med Hyg; 1986 Jan; 35(1):94-9. PubMed ID: 3946740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
    Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. African human trypanosomiasis in southern Sudan. Report of 77 cases.
    Wu SH
    Chin Med J (Engl); 1985 Jan; 98(1):37-41. PubMed ID: 3924497
    [No Abstract]   [Full Text] [Related]  

  • 29. Organic arsenic-induced Guillain-Barré-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study.
    Gherardi RK; Chariot P; Vanderstigel M; Malapert D; Verroust J; Astier A; Brun-Buisson C; Schaeffer A
    Muscle Nerve; 1990 Jul; 13(7):637-45. PubMed ID: 2167451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [African trypanosomiasis at the Claude-Bernard Hospital (diagnostic circumstances and therapeutic problems)].
    Coulaud JP; Vachon F; Lebigot P; Lagarde P; Pasticier A; Saimot G
    Ann Med Interne (Paris); 1975; 126(8-9):671-6. PubMed ID: 1217776
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy of CNS trypanosomiasis.
    Jennings FW
    Acta Trop; 1993 Sep; 54(3-4):205-13. PubMed ID: 7902658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.
    Adams JH; Haller L; Boa FY; Doua F; Dago A; Konian K
    Neuropathol Appl Neurobiol; 1986; 12(1):81-94. PubMed ID: 3703156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Three patients with African sleeping sickness following a visit to Tanzania].
    Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperendemic West African trypanosomiasis in a rural hospital setting.
    Weir AB; Agbowu J; Ajayi N
    J Trop Med Hyg; 1985 Oct; 88(5):307-11. PubMed ID: 3836307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic, selenium, and African trypanosomiasis.
    Golden MH
    Lancet; 1992 Jun; 339(8806):1413. PubMed ID: 1350819
    [No Abstract]   [Full Text] [Related]  

  • 38. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
    Chappuis F
    Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cutaneous lesions in human African trypanosomiasis].
    Tatibouet MH; Gentilini M; Brucker G
    Sem Hop; 1982 Nov; 58(40):2318-24. PubMed ID: 6297013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.